Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
GENE:
RET (Ret Proto-Oncogene)
i
Other names:
RET, Ret Proto-Oncogene, Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret, Cadherin-Related Family Member 16, Rearranged During Transfection, RET Receptor Tyrosine Kinase, Cadherin Family Member 12, Proto-Oncogene C-Ret, CDHF12, CDHR16, PTC, Ret Proto-Oncogene (Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1, Hirschsprung Disease), Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1, Hirschsprung Disease 1, RET-ELE1, HSCR1, MEN2A, MEN2B, RET51, MTC1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
5979
Related tests:
‹
FoundationOne® CDx (110)
Guardant360® CDx (54)
Oncomine™ Dx Target Test (11)
TruSight Oncology 500 Assay (3)
Guardant360 TissueNext™ (2)
Oncomine™ Comprehensive Assay v3M (2)
AmoyDx® Pan Lung Cancer PCR Panel (1)
Archer® FusionPlex® Comprehensive Thyroid & Lung (CTL) Kit (1)
Idylla™ GeneFusion Assay (1)
InVisionFirst®-Lung (1)
ACTOnco
AmoyDx® Essential NGS Panel
AmoyDx® HANDLE Classic NGS Panel
AnchorAIM® 10 Gene Test for Individualized Treatment of Lung Cancer
AnchorAIM® 72 gene detection for individualized treatment of solid tumors
Archer® FusionPlex® Lung Kit
Archer™ FusionPlex™ Core Solid Tumor Panel
Archer™ VARIANTPlex™ Complete Solid Tumor panel
Archer® VariantPlex® Comprehensive Thyroid and Lung (CTL) kit
Archer® VariantPlex® Solid Tumor Kit
ASPYRE-Lung
AVENIO ctDNA Expanded Kit
AVENIO ctDNA Surveillance Kit
AVENIO Tumor Tissue Expanded Kit
AVENIO Tumor Tissue Surveillance Kit
AVENIO Tumor Tissue Targeted Kit
Blueprint Genetics Comprehensive Hereditary Cancer Panel
BROCA Cancer Risk Panel
CancerNext-Expanded®
CustomNext-Cancer®
Find It®
Follow It®
FusionPlex® Dx
FusionPlex® Pan Solid Tumor v2 panel
GALEAS™ Tumor
GeneStrat® test
Guardant360® Liquid
HDPCR NSCLC RUO Assay
Labcorp® Plasma Focus™
LiquidGx™
LiquidHALLMARK®
LiquidPlex™
Liquid Trace Solid Tumor
Liquid Trace™ Solid Tumor
LungCure™ CDx
NeoLAB® Solid Tumor Liquid Biopsy
NeoTYPE® Lung Tumor Profile
NeXT Dx™ Test
NGS Targeted Hotspot Panel
Northstar Select™
NovoFocus™ NSCLC 2.0 Test
OncoGuide™ NCC Oncopanel System
OncoKey™ SL 60 Plus Assay
Oncomine Dx Express Test
Oncomine Focus Assay
Oncomine Lung Cell-Free Total Nucleic Acid Research Assay
Oncomine Precision Assay
Oncomine™ Comprehensive Assay Plus
Oncomine Tumor Mutation Load Assay
OncoPanel™ Assay
OncoPlus
oncoReveal™ Core LBx
oncoReveal™ Essential LBx
oncoReveal™ Fusion LBx Panel
oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel
oncoReveal™ Solid Tumor v2 Panel
OncoScreen™ Focus CDx Tissue Kit
Oncotype MAP™ Pan-Cancer Tissue Test
OptiSeq™ Lung Cancer Panel
OptiSeq™ Pan-Cancer Gene Panel
PGDx elio™ plasma resolve assay
PGDx elio™ tissue complete assay
PGLNext®
PredicineCARE™
Resolution ctDx Lung Assay™
SOPHiA DDM Dx RNAtarget Oncology Solution
SOPHiA DDM™ Solid Tumor Plus Solution
Target Selector™ NGS Lung Panel
Tempus xF Assay
Tempus xF+ Panel
Tempus xG+
Theralink Assay
ThyGeNEXT® + ThyraMIR®
TruSight Oncology Comprehensive
TruSight Tumor 15 Assay
TruSight Tumor 170 Assay
VarMap™ Pan-Cancer NGS Panel
FoundationOne® CDx (110)
Guardant360® CDx (54)
Oncomine™ Dx Target Test (11)
TruSight Oncology 500 Assay (3)
Guardant360 TissueNext™ (2)
Oncomine™ Comprehensive Assay v3M (2)
AmoyDx® Pan Lung Cancer PCR Panel (1)
Archer® FusionPlex® Comprehensive Thyroid & Lung (CTL) Kit (1)
Idylla™ GeneFusion Assay (1)
InVisionFirst®-Lung (1)
ACTOnco
AmoyDx® Essential NGS Panel
AmoyDx® HANDLE Classic NGS Panel
AnchorAIM® 10 Gene Test for Individualized Treatment of Lung Cancer
AnchorAIM® 72 gene detection for individualized treatment of solid tumors
Archer® FusionPlex® Lung Kit
Archer™ FusionPlex™ Core Solid Tumor Panel
Archer™ VARIANTPlex™ Complete Solid Tumor panel
Archer® VariantPlex® Comprehensive Thyroid and Lung (CTL) kit
Archer® VariantPlex® Solid Tumor Kit
ASPYRE-Lung
AVENIO ctDNA Expanded Kit
AVENIO ctDNA Surveillance Kit
AVENIO Tumor Tissue Expanded Kit
AVENIO Tumor Tissue Surveillance Kit
AVENIO Tumor Tissue Targeted Kit
Blueprint Genetics Comprehensive Hereditary Cancer Panel
BROCA Cancer Risk Panel
CancerNext-Expanded®
CustomNext-Cancer®
Find It®
Follow It®
FusionPlex® Dx
FusionPlex® Pan Solid Tumor v2 panel
GALEAS™ Tumor
GeneStrat® test
Guardant360® Liquid
HDPCR NSCLC RUO Assay
Labcorp® Plasma Focus™
LiquidGx™
LiquidHALLMARK®
LiquidPlex™
Liquid Trace Solid Tumor
Liquid Trace™ Solid Tumor
LungCure™ CDx
NeoLAB® Solid Tumor Liquid Biopsy
NeoTYPE® Lung Tumor Profile
NeXT Dx™ Test
NGS Targeted Hotspot Panel
Northstar Select™
NovoFocus™ NSCLC 2.0 Test
OncoGuide™ NCC Oncopanel System
OncoKey™ SL 60 Plus Assay
Oncomine Dx Express Test
Oncomine Focus Assay
Oncomine Lung Cell-Free Total Nucleic Acid Research Assay
Oncomine Precision Assay
Oncomine™ Comprehensive Assay Plus
Oncomine Tumor Mutation Load Assay
OncoPanel™ Assay
OncoPlus
oncoReveal™ Core LBx
oncoReveal™ Essential LBx
oncoReveal™ Fusion LBx Panel
oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel
oncoReveal™ Solid Tumor v2 Panel
OncoScreen™ Focus CDx Tissue Kit
Oncotype MAP™ Pan-Cancer Tissue Test
OptiSeq™ Lung Cancer Panel
OptiSeq™ Pan-Cancer Gene Panel
PGDx elio™ plasma resolve assay
PGDx elio™ tissue complete assay
PGLNext®
PredicineCARE™
Resolution ctDx Lung Assay™
SOPHiA DDM Dx RNAtarget Oncology Solution
SOPHiA DDM™ Solid Tumor Plus Solution
Target Selector™ NGS Lung Panel
Tempus xF Assay
Tempus xF+ Panel
Tempus xG+
Theralink Assay
ThyGeNEXT® + ThyraMIR®
TruSight Oncology Comprehensive
TruSight Tumor 15 Assay
TruSight Tumor 170 Assay
VarMap™ Pan-Cancer NGS Panel
›
Associations
(253)
News
Trials
VERI cancer hierarchy
Reset Filters
RET fusion
Non Small Cell Lung Cancer
RET fusion
Non Small Cell Lung Cancer
pralsetinib
Sensitive: A1 - Approval
pralsetinib
Sensitive
:
A1
pralsetinib
Sensitive: A1 - Approval
pralsetinib
Sensitive
:
A1
RET fusion
Non Small Cell Lung Cancer
RET fusion
Non Small Cell Lung Cancer
selpercatinib
Sensitive: A1 - Approval
selpercatinib
Sensitive
:
A1
selpercatinib
Sensitive: A1 - Approval
selpercatinib
Sensitive
:
A1
RET fusion
Thyroid Gland Carcinoma
RET fusion
Thyroid Gland Carcinoma
pralsetinib
Sensitive: A1 - Approval
pralsetinib
Sensitive
:
A1
pralsetinib
Sensitive: A1 - Approval
pralsetinib
Sensitive
:
A1
RET mutation
Thyroid Gland Medullary Carcinoma
RET mutation
Thyroid Gland Medullary Carcinoma
selpercatinib
Sensitive: A1 - Approval
selpercatinib
Sensitive
:
A1
selpercatinib
Sensitive: A1 - Approval
selpercatinib
Sensitive
:
A1
RET fusion
Thyroid Gland Carcinoma
RET fusion
Thyroid Gland Carcinoma
selpercatinib
Sensitive: A1 - Approval
selpercatinib
Sensitive
:
A1
selpercatinib
Sensitive: A1 - Approval
selpercatinib
Sensitive
:
A1
RET mutation
Thyroid Gland Medullary Carcinoma
RET mutation
Thyroid Gland Medullary Carcinoma
pralsetinib
Sensitive: A1 - Approval
pralsetinib
Sensitive
:
A1
pralsetinib
Sensitive: A1 - Approval
pralsetinib
Sensitive
:
A1
RET fusion
Solid Tumor
RET fusion
Solid Tumor
selpercatinib
Sensitive: A1 - Approval
selpercatinib
Sensitive
:
A1
selpercatinib
Sensitive: A1 - Approval
selpercatinib
Sensitive
:
A1
RET fusion
Thyroid Gland Oncocytic Carcinoma
RET fusion
Thyroid Gland Oncocytic Carcinoma
selpercatinib
Sensitive: A2 - Guideline
selpercatinib
Sensitive
:
A2
selpercatinib
Sensitive: A2 - Guideline
selpercatinib
Sensitive
:
A2
RET fusion
Thyroid Gland Follicular Carcinoma
RET fusion
Thyroid Gland Follicular Carcinoma
selpercatinib
Sensitive: A2 - Guideline
selpercatinib
Sensitive
:
A2
selpercatinib
Sensitive: A2 - Guideline
selpercatinib
Sensitive
:
A2
RET fusion
Thyroid Gland Papillary Carcinoma
RET fusion
Thyroid Gland Papillary Carcinoma
selpercatinib
Sensitive: A2 - Guideline
selpercatinib
Sensitive
:
A2
selpercatinib
Sensitive: A2 - Guideline
selpercatinib
Sensitive
:
A2
RET rearrangement
Non Small Cell Lung Cancer
RET rearrangement
Non Small Cell Lung Cancer
cabozantinib tablet
Sensitive: A2 - Guideline
cabozantinib tablet
Sensitive
:
A2
cabozantinib tablet
Sensitive: A2 - Guideline
cabozantinib tablet
Sensitive
:
A2
RET rearrangement
Non Small Cell Lung Cancer
RET rearrangement
Non Small Cell Lung Cancer
selpercatinib
Sensitive: A2 - Guideline
selpercatinib
Sensitive
:
A2
selpercatinib
Sensitive: A2 - Guideline
selpercatinib
Sensitive
:
A2
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.